ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,138Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 939

$1.05M Total Retail Price of All Prescriptions

Rank: 40 out of 939

616 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 17,133 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 874 736 1 2
AMLODIPINE BESYLATE 834 584 2 6
POTASSIUM CHLORIDE 701 568 3 9
LEVOTHYROXINE SODIUM 687 538 4 4
FUROSEMIDE 678 558 5 7
OMEPRAZOLE 539 355 6 5
MELOXICAM 514 331 7 14
METOPROLOL TARTRATE 509 386 8 10
GABAPENTIN 418 268 9 11
WARFARIN SODIUM 415 350 10 17
LISINOPRIL 406 304 11 3
CLONIDINE HCL 388 305 12 39
HYDROCODONE-ACETAMINOPHEN 369 252 S3 13 1
METFORMIN HCL 361 213 14 8
HYDROCHLOROTHIAZIDE 311 189 15 12
DONEPEZIL HCL 304 281 16 30
POLYETHYLENE GLYCOL 3350 295 256 17 57
PRAVASTATIN SODIUM 273 183 18 13
NAMENDA 261 258 19 49
METOPROLOL SUCCINATE 247 204 20 21
NEXIUM 246 142 21 18
SERTRALINE HCL 234 196 22 24
TAMSULOSIN HCL 227 163 23 27
LANTUS 226 162 24 59
FAMOTIDINE 220 178 25 62
DOXAZOSIN MESYLATE 209 177 26 108
BUSPIRONE HCL 193 172 27 123
CARVEDILOL 188 173 28 25
TRAZODONE HCL 171 116 29 26
PANTOPRAZOLE SODIUM 170 120 30 66
GLIPIZIDE 168 122 31 52
RANITIDINE HCL 163 122 32 35
CLOPIDOGREL 161 141 33 28
CITALOPRAM HBR 159 119 34 15
AZITHROMYCIN 152 125 35 32
LOSARTAN POTASSIUM 147 96 36 29
HALOPERIDOL 136 91 37 169
NAPROXEN 136 102 37 72
IPRATROPIUM-ALBUTEROL 132 119 39 178
ISOSORBIDE MONONITRATE ER 132 107 39 53
DOXYCYCLINE HYCLATE 128 75 41 84
FLUTICASONE PROPIONATE 126 77 42 43
BENZTROPINE MESYLATE 123 35 R 43 175
ALBUTEROL SULFATE 122 51 44 171
TRIAMTERENE-HCTZ 121 88 45 33
NIFEDICAL XL 118 107 46 259
OLANZAPINE 116 43 47 135
FLOVENT HFA 116 53 47 285
OXYBUTYNIN CHLORIDE 115 93 49 125
ALLOPURINOL 113 107 50 31
MIRTAZAPINE 111 100 51 56
HYDRALAZINE HCL 110 88 52 130
PLAVIX 110 101 52 48
CIPROFLOXACIN HCL 109 83 54 54
ENALAPRIL MALEATE 108 87 55 65
DIGOXIN 107 78 56 45
CYCLOBENZAPRINE HCL 104 44 R 57 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 78 58 23
MEGESTROL ACETATE 93 67 R 59 136
ALENDRONATE SODIUM 92 78 60 40
BENAZEPRIL HCL 92 59 60 87
DIVALPROEX SODIUM 91 60 62 95
COMBIVENT 91 51 62 120
ZOLPIDEM TARTRATE 89 76 64 20
PHENYTOIN SODIUM EXTENDED 86 34 65 99
ATENOLOL 86 72 65 19
LOVASTATIN 85 56 67 46
AGGRENOX 85 76 67 153
TRAMADOL HCL 82 46 69 16
RISPERIDONE 82 37 69 82
ATORVASTATIN CALCIUM 80 75 71 22
IBUPROFEN 79 39 72 112
CARBIDOPA-LEVODOPA 78 78 73 102
ESCITALOPRAM OXALATE 78 65 73 61
CRESTOR 76 61 75 34
PREDNISONE 75 44 76 42
LEVOFLOXACIN 73 54 77 86
DIOVAN 73 73 77 50
ACETAMINOPHEN-CODEINE 72 51 S3 79 116
INDAPAMIDE 72 68 79 173
AMITRIPTYLINE HCL 71 46 R 81 38
ETODOLAC 67 64 82 207
EXELON 65 65 83 151
METOCLOPRAMIDE HCL 64 57 84 119
VENLAFAXINE HCL 64 53 84 159
TERAZOSIN HCL 63 46 86 114
THEOPHYLLINE ANHYDROUS 63 25 86 225
VERAPAMIL ER 63 48 86 85
VALPROIC ACID 63 22 86 263
QUETIAPINE FUMARATE 63 42 86 69
VENTOLIN HFA 62 40 91 80
GEMFIBROZIL 62 19 91 100
GLYBURIDE 61 54 R 93 89
DIVALPROEX SODIUM ER 59 0 94 146
GLIMEPIRIDE 59 33 94 37
SINGULAIR 59 45 94 101
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 32 97 64
TRIAMTERENE-HYDROCHLOROTHIAZID 58 30 97 115
KLOR-CON M20 57 54 99 90
SUCRALFATE 57 38 99 96
PROAIR HFA 57 23 99 41
PREMARIN 56 39 R 102 111
CEPHALEXIN 56 40 102 77
CILOSTAZOL 55 49 104 219
MUPIROCIN 54 39 105 185
PHENYTOIN 54 42 105 288
TRAMADOL HCL-ACETAMINOPHEN 54 33 105 181
FLUOXETINE HCL 53 40 108 47
SODIUM CHLORIDE 53 49 108 304
INSULIN SYRINGE 53 37 108 97
SPIRONOLACTONE 51 40 111 71
BUDESONIDE 50 49 112 407
RAMIPRIL 50 50 112 91
GLIPIZIDE XL 50 40 112 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.